117 related articles for article (PubMed ID: 29353016)
1. Pyrosequencing analysis of methylation levels of clock genes in leukocytes from Parkinson's disease patients.
Mao W; Zhao C; Ding H; Liang K; Xue J; Chan P; Cai Y
Neurosci Lett; 2018 Mar; 668():115-119. PubMed ID: 29353016
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation analysis of seven clock genes in Parkinson's disease.
Lin Q; Ding H; Zheng Z; Gu Z; Ma J; Chen L; Chan P; Cai Y
Neurosci Lett; 2012 Jan; 507(2):147-50. PubMed ID: 22193177
[TBL] [Abstract][Full Text] [Related]
3. Pyrosequencing analysis of SNCA methylation levels in leukocytes from Parkinson's disease patients.
Song Y; Ding H; Yang J; Lin Q; Xue J; Zhang Y; Chan P; Cai Y
Neurosci Lett; 2014 May; 569():85-8. PubMed ID: 24721670
[TBL] [Abstract][Full Text] [Related]
4. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients.
Tan YY; Wu L; Zhao ZB; Wang Y; Xiao Q; Liu J; Wang G; Ma JF; Chen SD
Parkinsonism Relat Disord; 2014 Mar; 20(3):308-13. PubMed ID: 24398085
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro.
Coupland KG; Mellick GD; Silburn PA; Mather K; Armstrong NJ; Sachdev PS; Brodaty H; Huang Y; Halliday GM; Hallupp M; Kim WS; Dobson-Stone C; Kwok JB
Mov Disord; 2014 Nov; 29(13):1606-14. PubMed ID: 24375821
[TBL] [Abstract][Full Text] [Related]
6. Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability.
Pieper HC; Evert BO; Kaut O; Riederer PF; Waha A; Wüllner U
Neurobiol Dis; 2008 Dec; 32(3):521-7. PubMed ID: 18930140
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation of the 5'-UTR DAT 1 gene in Parkinson's disease patients.
Rubino A; D'Addario C; Di Bartolomeo M; Michele Salamone E; Locuratolo N; Fattapposta F; Vanacore N; Pascale E
Acta Neurol Scand; 2020 Sep; 142(3):275-280. PubMed ID: 32415851
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR.
Shih MC; Yeh KT; Tang KP; Chen JC; Chang JG
Mol Carcinog; 2006 Oct; 45(10):732-40. PubMed ID: 16683245
[TBL] [Abstract][Full Text] [Related]
9. Study of methylation levels of parkin gene promoter in Parkinson's disease patients.
Cai M; Tian J; Zhao GH; Luo W; Zhang BR
Int J Neurosci; 2011 Sep; 121(9):497-502. PubMed ID: 21663383
[TBL] [Abstract][Full Text] [Related]
10. A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma.
Franzoni A; Markova-Car E; Dević-Pavlić S; Jurišić D; Puppin C; Mio C; De Luca M; Petruz G; Damante G; Pavelić SK
Exp Biol Med (Maywood); 2017 Sep; 242(15):1553-1558. PubMed ID: 28799406
[TBL] [Abstract][Full Text] [Related]
11. Postnatal ontogenesis of molecular clock in mouse striatum.
Cai Y; Liu S; Li N; Xu S; Zhang Y; Chan P
Brain Res; 2009 Apr; 1264():33-8. PubMed ID: 19171124
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation of imprinted loci of autosomal chromosomes and IGF2 is not affected in Parkinson's disease patients' peripheral blood mononuclear cells.
Kaut O; Sharma A; Schmitt I; Wüllner U
Neurol Res; 2017 Mar; 39(3):281-284. PubMed ID: 28081695
[TBL] [Abstract][Full Text] [Related]
13. Cryptochromes impair phosphorylation of transcriptional activators in the clock: a general mechanism for circadian repression.
Dardente H; Fortier EE; Martineau V; Cermakian N
Biochem J; 2007 Mar; 402(3):525-36. PubMed ID: 17115977
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial D-Loop Region Methylation and Copy Number in Peripheral Blood DNA of Parkinson's Disease Patients.
Stoccoro A; Smith AR; Baldacci F; Del Gamba C; Lo Gerfo A; Ceravolo R; Lunnon K; Migliore L; Coppedè F
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065874
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic and DNA-binding characterization of the isolated heme-bound basic helix-loop-helix-PAS-A domain of neuronal PAS protein 2 (NPAS2), a transcription activator protein associated with circadian rhythms.
Mukaiyama Y; Uchida T; Sato E; Sasaki A; Sato Y; Igarashi J; Kurokawa H; Sagami I; Kitagawa T; Shimizu T
FEBS J; 2006 Jun; 273(11):2528-39. PubMed ID: 16704425
[TBL] [Abstract][Full Text] [Related]
16. L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro.
Schmitt I; Kaut O; Khazneh H; deBoni L; Ahmad A; Berg D; Klein C; Fröhlich H; Wüllner U
Mov Disord; 2015 Nov; 30(13):1794-801. PubMed ID: 26173746
[TBL] [Abstract][Full Text] [Related]
17. Formation of a repressive complex in the mammalian circadian clock is mediated by the secondary pocket of CRY1.
Michael AK; Fribourgh JL; Chelliah Y; Sandate CR; Hura GL; Schneidman-Duhovny D; Tripathi SM; Takahashi JS; Partch CL
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1560-1565. PubMed ID: 28143926
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson's disease.
Guhathakurta S; Evangelista BA; Ghosh S; Basu S; Kim YS
Mol Brain; 2017 Feb; 10(1):6. PubMed ID: 28173842
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential blood biomarkers for Parkinson's disease by gene expression and DNA methylation data integration analysis.
Wang C; Chen L; Yang Y; Zhang M; Wong G
Clin Epigenetics; 2019 Feb; 11(1):24. PubMed ID: 30744671
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of the NEUROG2 gene in patients with Parkinson's disease.
Deng S; Deng H; Le W; Xu H; Yang H; Deng X; Lv H; Xie W; Zhu S; Jankovic J
Neurosci Lett; 2010 Jan; 468(3):195-7. PubMed ID: 19879328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
